The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes
Martin K Rutter* and Richard W Nesto
Correspondence *Manchester Diabetes Centre, 193 Hathersage Road, Manchester M13 0JE, UK
Email martin.rutter@cmmc.nhs.uk
This Review examines the pros and cons of screening for coronary heart disease in asymptomatic subjects with diabetes. At present, there is insufficient evidence of clinical benefit to justify such a practice; therefore, carefully conducted clinical trials are urgently required to resolve the question.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroupKidney International Original Article
See all 11 matches for Research